Day: March 8, 2022
March 8, 2022: Oslo, Norway, the board of directors of PGS ASA (“PGS” or the “Company”) has approved the 2021 annual financial statements and annual report.
There are no material changes to the financial statements compared to the preliminary and unaudited full year results presented by the Company on January 27, 2022. The 2021 audit opinion from the Company’s auditor EY is without qualifications. However, the audit opinion includes an emphasis of matter related to material uncertainty pertaining to the going concern assumption.
As reported by the Company on January 27, 2022, the seismic market recovery in 2021 has been slower than assumed in the debt rescheduling business plan from 2020. As a result, there is a risk that the Company will not generate sufficient liquidity to repay the 2022 maturities whilst...
Leading Global Payment Card Integrator in Japan to Launch Biometric Smart Cards Based on IDEX Biometrics TrustedBio Solution
Written by Customer Service on . Posted in Public Companies.
Oslo, Norway – 08 March 2022 – IDEX Biometrics ASA has received an initial order from a new development partner, one of the world’s most advanced technology solution providers and global payment card integrators. The order is in support of a strategic development agreement between the companies that targets production later in 2022. As the global biometric payment market is reaching an inflection point towards mass production, this partnership will provide Japanese banks and issuers access to a biometric payment card with industry leading performance and cost efficiency.
The agreement covers joint development of biometric smart cards based on the IDEX Biometrics TrustedBio® turnkey reference design. The comprehensive solution platform includes the IDEX Biometric TrustedBio, integrated MCU/PMU, biometric software including proprietary...
Completion of seed assets transaction and update on portfolio
Written by Customer Service on . Posted in Mergers And Acquisitions.
8 March 2022
Foresight Sustainable Forestry Company Plc
Completion of seed assets transaction and update on portfolio
Foresight Sustainable Forestry Company Plc (“FSF“, “the Company”), an investment company that invests in UK forestry and afforestation assets, today announces the completion of its UK-wide seed assets portfolio transaction, the acquisition of an afforestation site at Maescastell in Wales, and the commencement of planting at Mountmill Burn, an afforestation site in Scotland. Together, these developments represent a materially significant milestone in FSF’s development.
Seed Portfolio Transaction
On 7 March 2022, FSF completed the seed assets portfolio transaction to acquire Blackmead Forestry Limited (“BFL”) and Blackmead Forestry II Limited (“BFL II”) from Foresight Inheritance Tax Solution for a total cost...
Interim Dividend on B Shares
Written by Customer Service on . Posted in Dividend Reports And Estimates.
Dividend Declaration
Seneca Growth Capital VCT Plc
8 March 2022
Seneca Growth Capital VCT Plc
Interim Dividend on B Shares
The Directors of Seneca Growth Capital VCT Plc (the “Company”) are pleased to declare an interim dividend of 1.5 pence per B Share for the year to 31 December 2022, to be paid on 20 May 2022.
The ex-dividend date is 5 May 2022.
The record date for the dividend is 6 May 2022.
On 29 October 2021 the Company launched an offer for subscription for B Shares to raise, in aggregate, up to £10 million with an over-allotment facility of up to a further £10 million (before issue costs) (the “Offer”). Full details of the Offer are contained in a prospectus issued by the Company on that date (the “Prospectus”).
Those investors seeking to invest under the Offer and benefit from the above dividend...
Roche to present new Evrysdi data at MDA 2022 and highlight expanding neuromuscular disease portfolio
Written by Customer Service on . Posted in Public Companies.
Evrysdi® (risdiplam) data further confirm long-term efficacy and safety data in a broad range of people with spinal muscular atrophy (SMA)
Latest interim results from the RAINBOWFISH study demonstrate that the majority of babies treated with Evrysdi for at least 12 months were able to sit, stand and walk within timeframes typical of healthy babies
New gene therapy data in boys living with Duchenne muscular dystrophy (DMD) reports encouraging results from early stage study supporting its progress into global pivotal Phase III EMBARK studyBasel, 08 March 2022 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new data from its growing neuromuscular portfolio will be presented at the Muscular Dystrophy Association (MDA) Clinical and Scientific Conference, 13 – 16 March 2022. Presentations include eight abstracts from its...
NOTICE ON CALLING THE ANNUAL GENERAL MEETING OF SHAREHOLDERS
Written by Customer Service on . Posted in Public Companies.
The Management Board of AS LHV Group (hereinafter the “Group“) hereby calls the general meeting of the shareholders, to be held at 13:00 on 30 March 2022 (Estonian time) at Hilton Tallinn Park Hotel, (Fr. R. Kreutzwaldi 23, Tallinn).
The list of shareholders who are entitled to participate in the general meeting will be determined as of 7 (seven) days before the general meeting, i.e., as at 23 March 2022 COB of Nasdaq CSD settlement system.
Registration of participants will start at the venue of the meeting at 12:00. Registration will end at 12:45. We kindly ask all shareholders and representatives to arrive as early as possible, taking into account the time required for registration.
Besides ordinary in-person voting, it is also possible to vote electronically on draft resolutions on the general meeting agenda, either using...
Avance Gas Holding Ltd. – Ex-dividend USD 0.05 today
Written by Customer Service on . Posted in Public Companies.
Bermuda, 8 March 2022 – Shares in Avance Gas Holding Ltd. will be traded ex-dividend USD 0.05 as of today.
For further information, please contact:
Randi Navdal BekkelundChief Financial OfficerTel: +47 22 00 48 29Email: randi.navdal@avancegas.com
About Avance Gas:Avance Gas operates in the global market for transportation of liquefied petroleum gas (LPG). The Company is one of the world’s leading owners and operators of very large gas carrier (VLGC) and operates a fleet of fourteen ships and 4 Dual Fuel LPG newbuildings due for delivery in Q4 2022 and Q1-Q4 2023. For more information about Avance Gas, please visit www.avancegas.com
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act
Communiqué Orange – ORANGE and MASMOVIL enter into exclusive discussions to combine their operations in Spain
Written by Customer Service on . Posted in Mergers And Acquisitions.
Press release8 mars 2022
ORANGE and MASMOVIL enter into exclusive discussions to combine their operations in Spain
ORANGE and MASMOVIL (LORCA JVCO) announced today that they have entered into exclusive discussions to combine their businesses in Spain1.
The combination would take the form of a 50-50 Joint Venture, co-controlled by ORANGE and MASMOVIL (LORCA JVCO) with a combined enterprise valuation of €19.6Bn. Valuations are attractive for both businesses, with ORANGE Spain’s enterprise value at €8.1 billion (7.5x 2022E EBITDAaL and 38.7x 2022E EBITDAaL – eCapex)2 and MASMOVIL’s (which includes the acquisition of EUSKALTEL) enterprise value at €11.5 billion (9.9x 2022E EBITDAaL and 17.8x 2022E EBITDAaL – eCapex)2.
ORANGE and LORCA JVCO would benefit from equal governance rights in the combined entity. Accordingly, neither ORANGE nor LORCA...
Inbank Audited Annual Report for 2021
Written by Customer Service on . Posted in Public Companies.
AS Inbank (Inbank) consolidated annual report 2021 has been enclosed to the announcement and will be made available on Inbank’s website at https://inbank.ee/en/investor/reports/.In 2021 Inbank earned a net profit of 11.0 million euros which is 86% more than the year before. The annual return on equity was 15.6%.
Inbank’s loan portfolio increased by 50% annually reaching 605 million euros. At the same time, the deposit portfolio grew 58%, reaching 618 million euros at year-end.
Total sales for 2021 was 498 million euros showing an increase of 66% compared to 2020. Growth was driven by sales finance, which amounted to almost 359 million euros or 74% more than a year earlier. Of the markets, Poland grew the fastest as expected, with sales volumes increasing 150% to 230 million euros.
By the end of 2021, Inbank had 804,000 active contracts...
Valneva Successfully Completes Pivotal Phase 3 Trial of Single-Shot Chikungunya Vaccine Candidate
Written by Customer Service on . Posted in Public Companies.
VLA1553-301 six-month follow-up completed – all endpoints met
Seroprotection (protective CHIKV neutralizing antibody levels) in 98.9% of participants after one month and 96.3% after six months
Good safety and tolerability profile confirmed
Valneva expects to commence pre-submission processSaint Herblain (France), March 8, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced the successful completion of the Phase 3 pivotal trial of its single-shot chikungunya vaccine candidate, VLA1553. The positive final analysis included six-month follow-up data and confirmed the topline results reported in August 2021. Valneva now expects to commence the pre-submission process with the U.S. Food and Drug Administration (FDA) in the second quarter of 2022.
The VLA1553-301 trial, which enrolled 4,115...